Objective: To investigate the effects of moderate-dose hydrocortisone on hemodynamic status in critically ill patients throughout the period of etomidate-related adrenal insufficiency.
Design: : Randomized, controlled, double-blind trial (NCT00862381).
Setting: University hospital emergency department and three intensive care units.